806 related articles for article (PubMed ID: 16423493)
21. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
[TBL] [Abstract][Full Text] [Related]
22. Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.
Sunagawa S; Fujita J; Higa F; Tateyama M; Haranaga S; Nakasone I; Yamane N; Uno T
J Antibiot (Tokyo); 2011 Aug; 64(8):539-45. PubMed ID: 21587266
[TBL] [Abstract][Full Text] [Related]
23. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.
Ardanuy C; Rolo D; Fenoll A; Tarrago D; Calatayud L; Liñares J
J Antimicrob Chemother; 2009 Sep; 64(3):507-10. PubMed ID: 19535383
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study.
Stratchounski LS; Kozlov RS; Appelbaum PC; Kretchikova OI; Kosowska-Shick K
Clin Microbiol Infect; 2006 Sep; 12(9):853-66. PubMed ID: 16882290
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
[TBL] [Abstract][Full Text] [Related]
26. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
27. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
28. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
[TBL] [Abstract][Full Text] [Related]
29. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
30. Sporadic occurrences of fluoroquinolone-resistant Streptococcus pneumoniae in the United States: longitudinal analysis of institutions from the New England and West South Central regions during the TRUST 4-9 (2000-2005) Surveillance Studies.
Davies TA; Yee YC; Amsler K; Goldschmidt R; Sahm DF; Evangelista AT
Postgrad Med; 2008 Sep; 120(3 Suppl 1):25-31. PubMed ID: 18931468
[TBL] [Abstract][Full Text] [Related]
31. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
Morrissey I; Colclough A; Northwood J
Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
33. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
Zhang FF; Zhao CJ; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
[TBL] [Abstract][Full Text] [Related]
34. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
[TBL] [Abstract][Full Text] [Related]
36. The relationship between serotypes and PFGE genotypes in isolates of Streptococcus pneumoniae from Hungary.
Dobay O; Rozgonyi F; Hajdú E; Nagy E; Knausz M; Amyes SG
Clin Microbiol Infect; 2005 Aug; 11(8):673-6. PubMed ID: 16008622
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002).
Marchese A; Gualco L; Cochetti I; Montanari MP; Speciale AM; Musumeci SR; Varaldo PE; Nicoletti G; Schito GC
Int J Antimicrob Agents; 2005 Aug; 26(2):138-45. PubMed ID: 16024234
[TBL] [Abstract][Full Text] [Related]
39. Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
DiPersio JR; Deshpande LM; Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):1-7. PubMed ID: 15629222
[TBL] [Abstract][Full Text] [Related]
40. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
